MedTrace Logo

Drinking Water PFAS, Pregnancy Outcome and Maternal Morbidity

NCT05810545 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 256659

Last updated 2023-04-18

No results posted yet for this study

Summary

The aim of the project is to assess the association between exposure to per- and polyfluoroalkyl substances (PFAS) via drinking water in pregnancy and birth outcomes (i.e. growth retardation, premature birth, and congenital developmental defects) and maternal morbidity (gestational hypertension, diabetes and preeclampsia) in a prospective population-wide register study.

Conditions

  • Birth Weight
  • Small for Gestational Age at Delivery
  • Large for Gestational Age at Delivery (Macrosomia)
  • Diabetes, Gestational
  • Hypertension in Pregnancy
  • Preeclampsia
  • Congenital Malformation

Interventions

OTHER

Per- and polyfluoroalkyl substances (PFAS)

Assess the association between exposure to per- and polyfluoroalkyl substances (PFAS) via drinking water in pregnancy and birth outcomes (i.e. growth retardation, premature birth, and congenital developmental defects) and maternal morbidity (gestational hypertension, diabetes and preeclampsia) in a prospective population-wide register based cohort.

Sponsors & Collaborators

  • The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)

    collaborator OTHER_GOV

  • The Swedish Research Council

    collaborator OTHER_GOV

  • Statistics Sweden

    collaborator UNKNOWN

  • National Board of Health and Welfare, Sweden

    collaborator OTHER_GOV

  • Swedish University of Agricultural Sciences

    collaborator OTHER

  • Swedish Food Agency

    collaborator UNKNOWN

  • Karolinska Institutet

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-01
Primary Completion
2018-12-31
Completion
2018-12-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05810545 on ClinicalTrials.gov